Department of Medicinal Chemistry, School of Pharmacy, Shandong University, Jinan, Shandong, 250012, China.
Med Chem. 2013 Feb;9(1):126-32. doi: 10.2174/157340613804488314.
Histone deacetylases (HDACs) belong to a superfamily of enzymes responsible for deacetylating the Nterminal tails of histones. Overproduction of HDACs has a significant role in tumorigenesis. Accordingly, inhibition of HDACs has been widely applied for cancer therapy. It is encouraging that some natural products showed promising potency and selectivity against HDACs. In order to uncover their keys of good performance, the binding patterns of several natural HDAC1 inhibitors in the active site of HDAC1 were navigated by homology modeling, docking and molecular dynamic simulations. Evaluation of the binding poses allowed us to recognize the roles of different residues around the active site, and to understand the core features in the structure of the inhibitor molecule. Hydrophobic and H-bond interactions formed between the ligand and residues were discovered to make significant contributions to the ligand-receptor binding. Finally, the structural requirement of inhibitors for binding to HDAC1 was well proposed. Our results are beneficial to the design of potent HDAC1 inhibitors.
组蛋白去乙酰化酶(HDACs)属于一组负责脱乙酰化组蛋白 N 端尾巴的酶。HDACs 的过度产生在肿瘤发生中起着重要作用。因此,抑制 HDACs 已被广泛应用于癌症治疗。令人鼓舞的是,一些天然产物对 HDACs 表现出了有希望的活性和选择性。为了揭示它们的良好性能的关键,通过同源建模、对接和分子动力学模拟,对几种天然 HDAC1 抑制剂在 HDAC1 活性部位的结合模式进行了探索。对结合构象的评估使我们能够识别活性部位周围不同残基的作用,并了解抑制剂分子结构中的核心特征。发现配体与残基之间形成的疏水和氢键相互作用对配体-受体结合有重要贡献。最后,提出了抑制剂与 HDAC1 结合的结构要求。我们的研究结果有助于设计有效的 HDAC1 抑制剂。